Resar
Scoring methodologyReview policyConflicts disclosedNot medical advice
Nordic Naturals4.7 (8,890)AI-curated evidence

Triglyceride Omega-3 Fish Oil (2g EPA+DHA per serving)

A triglyceride-form fish oil delivering 2 g combined EPA and DHA per serving. Dosage matters: cardiovascular benefits in trials cluster at higher daily EPA/DHA intakes.

Ingredient-level evidence4 papers indexed · 4 claims mapped

Resar evidence panel

0–100 · cited research only

Evidence Score

90

Excellent

Safety Score

59

Good

Effectiveness Score

81

Strong

Research Confidence

82

Strong

Product Fit Score

68

Good

Bottom line

Strong evidence (Excellent) for heart health — worth a closer look if this fits your goals.

Individual results vary. Summaries are educational — not medical advice.

Triglyceride Omega-3 Fish Oil (2g EPA+DHA per serving)

Evidence Score

90

Excellent

Price

$45.95

Buy on Amazon

Resar may earn an affiliate commission on this purchase. Commissions never change scores — see our affiliate disclosure and conflicts policy. Scores reflect cited research, not medical advice.

Compare others in Heart Health

Claim ledger

Every claim, mapped to its source

Each product claim below is tied to a specific paper with study type, match strength, and limitations. Nothing here is medical advice — it is a research trail you can audit.

Claim match reflects how closely a specific paper supports this benefit — not AI confidence or medical certainty.

Full evidence detail

Study-by-study breakdown

Each paper below is ranked for this listing. Start with the highest match, then expand any study for a plain-language readout.

How to read this section

  • Match % - how closely the study matches this product (not overall scientific quality).
  • Evidence type - study design (RCT, review, etc.) and whether it is direct, category-level, or indirect.
  • What it found - short summary and quoted extract from the paper metadata. Not medical advice.
Ingredient-level evidenceThis study is related to the product category, but may not match this exact listing.

In plain language

Meta-analysis of 13 trials (127,477 participants) found marine omega-3 supplementation was associated with lower risk of myocardial infarction and coronary heart disease death, with risk reductions growing at higher doses. [1]

What the study reported

Verified extract — not AI generated

Significant reductions in several cardiac endpoints; effect strengthened with higher daily EPA+DHA.

Dose in the study

Benefit associated with doses above ~1 g/day, strengthening toward 2-4 g/day.

Side effects noted

Omega-3 supplements were generally safe; mild GI upset and a small increase in atrial fibrillation risk noted in some high-dose trials.

Caveats

Trials varied in dose, formulation and populations; not all endpoints (e.g., stroke) showed benefit.

Read original study

Transparency

Score history

Human review is pending for this listing.

No score changes have been recorded yet.

Reviews

Shopper feedback

4.7

average rating

8,890 Amazon reviews were available from the listing metadata.